Fund
EIFO
EIFO took part in the round of Breye Therapeutics (67,5 M€, Series A) on 29 September 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 29 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 29 Sept | Denmark, Biotech | Series A | 67,5 M€ | Participant |
Co investors 8 funds crossed
- Catalyze Capital 1 operation
- Innovestor Life Science 1 operation
- Ljungström family office 1 operation
- Mission BioCapital 1 operation
- Modi Ventures 1 operation
- Novo Holdings 1 operation
- Pappas Capital 1 operation
- Sound Bioventures 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Denmark.